Oncological Resectability Criteria for Hepatocellular Carcinoma in the Era of Novel Systemic Therapies: The Japan Liver Cancer Association and Japanese Society of Hepato-Biliary-Pancreatic Surgery Expert Consensus Statement 2023
Keiichi Akahoshi(Tokyo Medical and Dental University), Norihiro Kokudo(National Center for Global Health and Medicine), Masafumi Nakamura(Kyushu University), Susumu Eguchi(Nagasaki University), Yukiyasu Okamura(Hakodate Central General Hospital), Tomoharu Yoshizumi(Kyushu University), Itaru Endo(Yokohama City University), Shoji Kubo(Osaka Metropolitan University), Masaki Kaibori(Kansai Medical University), Etsuro Hatano(Kyoto University), Kiyoshi Hasegawa(Bunkyo University), Mitsuo Shimada(Tokushima University), Hiroaki Nagano(Kyushu University), Akinobu Taketomi(Hokkaido University), Junichi Shindoh(Toranomon Hospital), Shun‐ichi Ariizumi(Tokyo Women's Medical University), Minoru Tanabe(Tokyo Institute of Technology), Nobuyuki Takemura(National Center for Global Health and Medicine)
Cited by 52
Related Papers
Pan-cancer analysis of whole genomes
|Nature|2020|3.3k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
|Journal of Hepatology|2003|1.6k
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
|Nature Genetics|2014|780